Skip to main content

Birchview Capital, LP

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1618205 BURLINGTON, VT

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
14,000
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Birchview Capital, LP holds $91,246,272 across 49 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 14,000
2025-12-31 14,000
2025-09-30 14,000
2025-06-30 14,000
2025-03-31 14,000
2024-12-31 14,000
2024-09-30 14,000
2024-06-30 14,000
2024-03-31 18,000
2023-12-31 18,000
2023-09-30 18,000
2023-06-30 12,000
2023-03-31 12,000
2022-12-31 12,000
2022-09-30 12,000
2022-06-30 12,000
2022-03-31 12,000
2021-12-31 12,000
2021-09-30 12,000
2021-06-30 8,000
2021-03-31 8,000
2020-12-31 8,000
2020-09-30 8,000
2020-06-30 8,000
2020-03-31 8,000